Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1616587
PUBLISHER: KBV Research | PRODUCT CODE: 1616587
Asia Pacific Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model, By Therapeutic Area, By Country and Growth Forecast, 2024 - 2031
PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Asia Pacific Biosimulation Market would witness market growth of 17.8% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Biosimulation Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $697.5 million by 2031. The Japan market is registering a CAGR of 17.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 18.5% during (2024 - 2031).
Technological advancements in cloud computing and high-performance computing have further democratized access to these tools. Cloud-based platforms allow researchers and organizations to perform complex simulations without significant infrastructure investments. This accessibility has benefited small and mid-sized biotech firms, which can now compete with larger players in developing innovative therapies.
The growing focus on biologics and biosimilars has significantly increased the demand for these technologies. Biologics, such as monoclonal antibodies, cell therapies, and vaccines, rely on complex biological systems, requiring advanced tools to model their interactions effectively. They accelerates their development by predicting how these therapies interact with targets in the body, enabling researchers to refine designs before clinical trials.
Australia's market is uniquely positioned, benefiting from its world-class clinical trial ecosystem and government-backed programs like the Medical Research Future Fund (MRFF). Moreover, the growing prevalence of chronic diseases presents a significant public health challenge, with over 15.4 million individuals living with at least one chronic condition, as reported by the Australian Institute of Health and Welfare (AIHW). This widespread burden underscores the importance of biosimulation technologies in addressing the nation's healthcare needs. Thus, the region will present lucrative growth opportunities to expand the market.
Based on Product, the market is segmented into Software (Molecular Modeling & Simulation Software, Clinical Trial Design Software, PK/PD Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Toxicity Prediction Software, and Other Software Type) and Services (Contract Services, Consulting, and Other Services Type). Based on Pricing Model, the market is segmented into License-based Model, Subscription-based Model, Service-based Model, and Pay Per Use Model. Based on End Use, the market is segmented into Life Sciences Companies, Academic Research Institutions, and Other End Use. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling, and Other Application. Based on Deployment Model, the market is segmented into Cloud-based, On-premises, and Hybrid Model. Based on Therapeutic Area, the market is segmented into Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Other Therapeutic Area. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Certara, Inc.
- Dassault Systemes SE
- Advanced Chemistry Development, Inc.
- Genedata AG (Danaher Corporation)
- Instem Group of Companies
- Chemical Computing Group ULC
- Simulations Plus, Inc.
- Schrodinger, Inc.
- PPD, Inc. (Thermo Fisher Scientific, Inc.)
- Physiomics Plc
Asia Pacific Biosimulation Market Report Segmentation
By Product
- Software
- Molecular Modeling & Simulation Software
- Clinical Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Toxicity Prediction Software
- Other Software Type
- Services
- Contract Services
- Consulting
- Other Services Type
By Pricing Model
- License-based Model
- Subscription-based Model
- Service-based Model
- Pay Per Use Model
By End Use
- Life Sciences Companies
- Academic Research Institutions
- Other End Use
By Application
- Drug Discovery & Development
- Disease Modeling
- Other Application
By Deployment Model
- Cloud-based
- On-premises
- Hybrid Model
By Therapeutic Area
- Oncology
- Cardiovascular Disease
- Infectious Disease
- Neurological Disorders
- Other Therapeutic Area
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Biosimulation Market, by Product
- 1.4.2 Asia Pacific Biosimulation Market, by Pricing Model
- 1.4.3 Asia Pacific Biosimulation Market, by End Use
- 1.4.4 Asia Pacific Biosimulation Market, by Application
- 1.4.5 Asia Pacific Biosimulation Market, by Deployment Model
- 1.4.6 Asia Pacific Biosimulation Market, by Therapeutic Area
- 1.4.7 Asia Pacific Biosimulation Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
- 4.1 Market Share Analysis, 2023
- 4.2 Strategies Deployed in Biosimulation Market
- 4.3 Porter Five Forces Analysis
Chapter 5. Asia Pacific Biosimulation Market by Product
- 5.1 Asia Pacific Software Market by Country
- 5.2 Asia Pacific Biosimulation Market by Software Type
- 5.2.1 Asia Pacific Molecular Modeling & Simulation Software Market by Country
- 5.2.2 Asia Pacific Clinical Trial Design Software Market by Country
- 5.2.3 Asia Pacific PK/PD Modeling and Simulation Software Market by Country
- 5.2.4 Asia Pacific Pbpk Modeling and Simulation Software Market by Country
- 5.2.5 Asia Pacific Toxicity Prediction Software Market by Country
- 5.2.6 Asia Pacific Other Software Type Market by Country
- 5.3 Asia Pacific Services Market by Country
- 5.4 Asia Pacific Biosimulation Market by Services Type
- 5.4.1 Asia Pacific Contract Services Market by Country
- 5.4.2 Asia Pacific Consulting Market by Country
- 5.4.3 Asia Pacific Other Services Type Market by Country
Chapter 6. Asia Pacific Biosimulation Market by Pricing Model
- 6.1 Asia Pacific License-based Model Market by Country
- 6.2 Asia Pacific Subscription-based Model Market by Country
- 6.3 Asia Pacific Service-based Model Market by Country
- 6.4 Asia Pacific Pay Per Use Model Market by Country
Chapter 7. Asia Pacific Biosimulation Market by End Use
- 7.1 Asia Pacific Life Sciences Companies Market by Country
- 7.2 Asia Pacific Academic Research Institutions Market by Country
- 7.3 Asia Pacific Other End Use Market by Country
Chapter 8. Asia Pacific Biosimulation Market by Application
- 8.1 Asia Pacific Drug Discovery & Development Market by Country
- 8.2 Asia Pacific Disease Modeling Market by Country
- 8.3 Asia Pacific Other Application Market by Country
Chapter 9. Asia Pacific Biosimulation Market by Deployment Model
- 9.1 Asia Pacific Cloud-based Market by Country
- 9.2 Asia Pacific On-premises Market by Country
- 9.3 Asia Pacific Hybrid Model Market by Country
Chapter 10. Asia Pacific Biosimulation Market by Therapeutic Area
- 10.1 Asia Pacific Oncology Market by Country
- 10.2 Asia Pacific Cardiovascular Disease Market by Country
- 10.3 Asia Pacific Infectious Disease Market by Country
- 10.4 Asia Pacific Neurological Disorders Market by Country
- 10.5 Asia Pacific Other Therapeutic Area Market by Country
Chapter 11. Asia Pacific Biosimulation Market by Country
- 11.1 China Biosimulation Market
- 11.1.1 China Biosimulation Market by Product
- 11.1.1.1 China Biosimulation Market by Software Type
- 11.1.1.2 China Biosimulation Market by Services Type
- 11.1.2 China Biosimulation Market by Pricing Model
- 11.1.3 China Biosimulation Market by End Use
- 11.1.4 China Biosimulation Market by Application
- 11.1.5 China Biosimulation Market by Deployment Model
- 11.1.6 China Biosimulation Market by Therapeutic Area
- 11.1.1 China Biosimulation Market by Product
- 11.2 Japan Biosimulation Market
- 11.2.1 Japan Biosimulation Market by Product
- 11.2.1.1 Japan Biosimulation Market by Software Type
- 11.2.1.2 Japan Biosimulation Market by Services Type
- 11.2.2 Japan Biosimulation Market by Pricing Model
- 11.2.3 Japan Biosimulation Market by End Use
- 11.2.4 Japan Biosimulation Market by Application
- 11.2.5 Japan Biosimulation Market by Deployment Model
- 11.2.6 Japan Biosimulation Market by Therapeutic Area
- 11.2.1 Japan Biosimulation Market by Product
- 11.3 India Biosimulation Market
- 11.3.1 India Biosimulation Market by Product
- 11.3.1.1 India Biosimulation Market by Software Type
- 11.3.1.2 India Biosimulation Market by Services Type
- 11.3.2 India Biosimulation Market by Pricing Model
- 11.3.3 India Biosimulation Market by End Use
- 11.3.4 India Biosimulation Market by Application
- 11.3.5 India Biosimulation Market by Deployment Model
- 11.3.6 India Biosimulation Market by Therapeutic Area
- 11.3.1 India Biosimulation Market by Product
- 11.4 South Korea Biosimulation Market
- 11.4.1 South Korea Biosimulation Market by Product
- 11.4.1.1 South Korea Biosimulation Market by Software Type
- 11.4.1.2 South Korea Biosimulation Market by Services Type
- 11.4.2 South Korea Biosimulation Market by Pricing Model
- 11.4.3 South Korea Biosimulation Market by End Use
- 11.4.4 South Korea Biosimulation Market by Application
- 11.4.5 South Korea Biosimulation Market by Deployment Model
- 11.4.6 South Korea Biosimulation Market by Therapeutic Area
- 11.4.1 South Korea Biosimulation Market by Product
- 11.5 Singapore Biosimulation Market
- 11.5.1 Singapore Biosimulation Market by Product
- 11.5.1.1 Singapore Biosimulation Market by Software Type
- 11.5.1.2 Singapore Biosimulation Market by Services Type
- 11.5.2 Singapore Biosimulation Market by Pricing Model
- 11.5.3 Singapore Biosimulation Market by End Use
- 11.5.4 Singapore Biosimulation Market by Application
- 11.5.5 Singapore Biosimulation Market by Deployment Model
- 11.5.6 Singapore Biosimulation Market by Therapeutic Area
- 11.5.1 Singapore Biosimulation Market by Product
- 11.6 Malaysia Biosimulation Market
- 11.6.1 Malaysia Biosimulation Market by Product
- 11.6.1.1 Malaysia Biosimulation Market by Software Type
- 11.6.1.2 Malaysia Biosimulation Market by Services Type
- 11.6.2 Malaysia Biosimulation Market by Pricing Model
- 11.6.3 Malaysia Biosimulation Market by End Use
- 11.6.4 Malaysia Biosimulation Market by Application
- 11.6.5 Malaysia Biosimulation Market by Deployment Model
- 11.6.6 Malaysia Biosimulation Market by Therapeutic Area
- 11.6.1 Malaysia Biosimulation Market by Product
- 11.7 Rest of Asia Pacific Biosimulation Market
- 11.7.1 Rest of Asia Pacific Biosimulation Market by Product
- 11.7.1.1 Rest of Asia Pacific Biosimulation Market by Software Type
- 11.7.1.2 Rest of Asia Pacific Biosimulation Market by Services Type
- 11.7.2 Rest of Asia Pacific Biosimulation Market by Pricing Model
- 11.7.3 Rest of Asia Pacific Biosimulation Market by End Use
- 11.7.4 Rest of Asia Pacific Biosimulation Market by Application
- 11.7.5 Rest of Asia Pacific Biosimulation Market by Deployment Model
- 11.7.6 Rest of Asia Pacific Biosimulation Market by Therapeutic Area
- 11.7.1 Rest of Asia Pacific Biosimulation Market by Product
Chapter 12. Company Profiles
- 12.1 Certara, Inc.
- 12.1.1 Company Overview
- 12.1.2 Financial Analysis
- 12.1.3 Regional Analysis
- 12.1.4 Research & Development Expenses
- 12.1.5 Recent strategies and developments:
- 12.1.5.1 Product Launches and Product Expansions:
- 12.1.5.2 Acquisition and Mergers:
- 12.1.6 SWOT Analysis
- 12.2 Dassault Systemes SE
- 12.2.1 Company Overview
- 12.2.2 Financial Analysis
- 12.2.3 Regional Analysis
- 12.2.4 Research & Development Expense
- 12.2.5 SWOT Analysis
- 12.3 Advanced Chemistry Development, Inc.
- 12.3.1 Company Overview
- 12.4 Genedata AG (Danaher Corporation)
- 12.4.1 Company Overview
- 12.4.2 Financial Analysis
- 12.4.3 Segmental and Regional Analysis
- 12.4.4 Research & Development Expense
- 12.4.5 Recent strategies and developments:
- 12.4.5.1 Partnerships, Collaborations, and Agreements:
- 12.5 Instem Group of Companies
- 12.5.1 Company Overview
- 12.6 Chemical Computing Group ULC
- 12.6.1 Company Overview
- 12.7 Simulations Plus, Inc.
- 12.7.1 Company Overview
- 12.7.2 Financial Analysis
- 12.7.3 Segmental and Regional Analysis
- 12.7.4 Research & Development Expenses
- 12.7.5 Recent strategies and developments:
- 12.7.5.1 Partnerships, Collaborations, and Agreements:
- 12.7.5.2 Product Launches and Product Expansions:
- 12.7.5.3 Acquisition and Mergers:
- 12.7.6 SWOT Analysis
- 12.8 Schrodinger, Inc.
- 12.8.1 Company Overview
- 12.8.2 Financial Analysis
- 12.8.3 Segmental and Regional Analysis
- 12.8.4 Research & Development Expenses
- 12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
- 12.9.1 Company Overview
- 12.9.2 Financial Analysis
- 12.9.3 Segmental and Regional Analysis
- 12.9.4 Research & Development Expenses
- 12.10. Physiomics Plc
- 12.10.1 Company Overview
- 12.10.2 Financial Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific Biosimulation Market, 2020 - 2023, USD Million
- TABLE 2 Asia Pacific Biosimulation Market, 2024 - 2031, USD Million
- TABLE 3 Asia Pacific Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 4 Asia Pacific Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 5 Asia Pacific Software Market by Country, 2020 - 2023, USD Million
- TABLE 6 Asia Pacific Software Market by Country, 2024 - 2031, USD Million
- TABLE 7 Asia Pacific Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 8 Asia Pacific Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 9 Asia Pacific Molecular Modeling & Simulation Software Market by Country, 2020 - 2023, USD Million
- TABLE 10 Asia Pacific Molecular Modeling & Simulation Software Market by Country, 2024 - 2031, USD Million
- TABLE 11 Asia Pacific Clinical Trial Design Software Market by Country, 2020 - 2023, USD Million
- TABLE 12 Asia Pacific Clinical Trial Design Software Market by Country, 2024 - 2031, USD Million
- TABLE 13 Asia Pacific PK/PD Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
- TABLE 14 Asia Pacific PK/PD Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
- TABLE 15 Asia Pacific Pbpk Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
- TABLE 16 Asia Pacific Pbpk Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
- TABLE 17 Asia Pacific Toxicity Prediction Software Market by Country, 2020 - 2023, USD Million
- TABLE 18 Asia Pacific Toxicity Prediction Software Market by Country, 2024 - 2031, USD Million
- TABLE 19 Asia Pacific Other Software Type Market by Country, 2020 - 2023, USD Million
- TABLE 20 Asia Pacific Other Software Type Market by Country, 2024 - 2031, USD Million
- TABLE 21 Asia Pacific Services Market by Country, 2020 - 2023, USD Million
- TABLE 22 Asia Pacific Services Market by Country, 2024 - 2031, USD Million
- TABLE 23 Asia Pacific Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 24 Asia Pacific Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 25 Asia Pacific Contract Services Market by Country, 2020 - 2023, USD Million
- TABLE 26 Asia Pacific Contract Services Market by Country, 2024 - 2031, USD Million
- TABLE 27 Asia Pacific Consulting Market by Country, 2020 - 2023, USD Million
- TABLE 28 Asia Pacific Consulting Market by Country, 2024 - 2031, USD Million
- TABLE 29 Asia Pacific Other Services Type Market by Country, 2020 - 2023, USD Million
- TABLE 30 Asia Pacific Other Services Type Market by Country, 2024 - 2031, USD Million
- TABLE 31 Asia Pacific Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 32 Asia Pacific Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 33 Asia Pacific License-based Model Market by Country, 2020 - 2023, USD Million
- TABLE 34 Asia Pacific License-based Model Market by Country, 2024 - 2031, USD Million
- TABLE 35 Asia Pacific Subscription-based Model Market by Country, 2020 - 2023, USD Million
- TABLE 36 Asia Pacific Subscription-based Model Market by Country, 2024 - 2031, USD Million
- TABLE 37 Asia Pacific Service-based Model Market by Country, 2020 - 2023, USD Million
- TABLE 38 Asia Pacific Service-based Model Market by Country, 2024 - 2031, USD Million
- TABLE 39 Asia Pacific Pay Per Use Model Market by Country, 2020 - 2023, USD Million
- TABLE 40 Asia Pacific Pay Per Use Model Market by Country, 2024 - 2031, USD Million
- TABLE 41 Asia Pacific Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 42 Asia Pacific Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 43 Asia Pacific Life Sciences Companies Market by Country, 2020 - 2023, USD Million
- TABLE 44 Asia Pacific Life Sciences Companies Market by Country, 2024 - 2031, USD Million
- TABLE 45 Asia Pacific Academic Research Institutions Market by Country, 2020 - 2023, USD Million
- TABLE 46 Asia Pacific Academic Research Institutions Market by Country, 2024 - 2031, USD Million
- TABLE 47 Asia Pacific Other End Use Market by Country, 2020 - 2023, USD Million
- TABLE 48 Asia Pacific Other End Use Market by Country, 2024 - 2031, USD Million
- TABLE 49 Asia Pacific Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 50 Asia Pacific Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 51 Asia Pacific Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
- TABLE 52 Asia Pacific Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
- TABLE 53 Asia Pacific Disease Modeling Market by Country, 2020 - 2023, USD Million
- TABLE 54 Asia Pacific Disease Modeling Market by Country, 2024 - 2031, USD Million
- TABLE 55 Asia Pacific Other Application Market by Country, 2020 - 2023, USD Million
- TABLE 56 Asia Pacific Other Application Market by Country, 2024 - 2031, USD Million
- TABLE 57 Asia Pacific Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 58 Asia Pacific Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 59 Asia Pacific Cloud-based Market by Country, 2020 - 2023, USD Million
- TABLE 60 Asia Pacific Cloud-based Market by Country, 2024 - 2031, USD Million
- TABLE 61 Asia Pacific On-premises Market by Country, 2020 - 2023, USD Million
- TABLE 62 Asia Pacific On-premises Market by Country, 2024 - 2031, USD Million
- TABLE 63 Asia Pacific Hybrid Model Market by Country, 2020 - 2023, USD Million
- TABLE 64 Asia Pacific Hybrid Model Market by Country, 2024 - 2031, USD Million
- TABLE 65 Asia Pacific Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 66 Asia Pacific Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 67 Asia Pacific Oncology Market by Country, 2020 - 2023, USD Million
- TABLE 68 Asia Pacific Oncology Market by Country, 2024 - 2031, USD Million
- TABLE 69 Asia Pacific Cardiovascular Disease Market by Country, 2020 - 2023, USD Million
- TABLE 70 Asia Pacific Cardiovascular Disease Market by Country, 2024 - 2031, USD Million
- TABLE 71 Asia Pacific Infectious Disease Market by Country, 2020 - 2023, USD Million
- TABLE 72 Asia Pacific Infectious Disease Market by Country, 2024 - 2031, USD Million
- TABLE 73 Asia Pacific Neurological Disorders Market by Country, 2020 - 2023, USD Million
- TABLE 74 Asia Pacific Neurological Disorders Market by Country, 2024 - 2031, USD Million
- TABLE 75 Asia Pacific Other Therapeutic Area Market by Country, 2020 - 2023, USD Million
- TABLE 76 Asia Pacific Other Therapeutic Area Market by Country, 2024 - 2031, USD Million
- TABLE 77 Asia Pacific Biosimulation Market by Country, 2020 - 2023, USD Million
- TABLE 78 Asia Pacific Biosimulation Market by Country, 2024 - 2031, USD Million
- TABLE 79 China Biosimulation Market, 2020 - 2023, USD Million
- TABLE 80 China Biosimulation Market, 2024 - 2031, USD Million
- TABLE 81 China Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 82 China Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 83 China Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 84 China Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 85 China Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 86 China Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 87 China Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 88 China Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 89 China Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 90 China Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 91 China Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 92 China Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 93 China Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 94 China Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 95 China Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 96 China Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 97 Japan Biosimulation Market, 2020 - 2023, USD Million
- TABLE 98 Japan Biosimulation Market, 2024 - 2031, USD Million
- TABLE 99 Japan Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 100 Japan Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 101 Japan Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 102 Japan Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 103 Japan Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 104 Japan Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 105 Japan Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 106 Japan Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 107 Japan Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 108 Japan Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 109 Japan Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 110 Japan Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 111 Japan Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 112 Japan Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 113 Japan Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 114 Japan Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 115 India Biosimulation Market, 2020 - 2023, USD Million
- TABLE 116 India Biosimulation Market, 2024 - 2031, USD Million
- TABLE 117 India Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 118 India Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 119 India Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 120 India Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 121 India Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 122 India Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 123 India Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 124 India Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 125 India Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 126 India Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 127 India Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 128 India Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 129 India Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 130 India Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 131 India Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 132 India Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 133 South Korea Biosimulation Market, 2020 - 2023, USD Million
- TABLE 134 South Korea Biosimulation Market, 2024 - 2031, USD Million
- TABLE 135 South Korea Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 136 South Korea Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 137 South Korea Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 138 South Korea Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 139 South Korea Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 140 South Korea Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 141 South Korea Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 142 South Korea Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 143 South Korea Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 144 South Korea Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 145 South Korea Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 146 South Korea Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 147 South Korea Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 148 South Korea Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 149 South Korea Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 150 South Korea Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 151 Singapore Biosimulation Market, 2020 - 2023, USD Million
- TABLE 152 Singapore Biosimulation Market, 2024 - 2031, USD Million
- TABLE 153 Singapore Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 154 Singapore Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 155 Singapore Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 156 Singapore Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 157 Singapore Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 158 Singapore Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 159 Singapore Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 160 Singapore Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 161 Singapore Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 162 Singapore Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 163 Singapore Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 164 Singapore Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 165 Singapore Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 166 Singapore Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 167 Singapore Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 168 Singapore Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 169 Malaysia Biosimulation Market, 2020 - 2023, USD Million
- TABLE 170 Malaysia Biosimulation Market, 2024 - 2031, USD Million
- TABLE 171 Malaysia Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 172 Malaysia Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 173 Malaysia Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 174 Malaysia Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 175 Malaysia Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 176 Malaysia Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 177 Malaysia Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 178 Malaysia Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 179 Malaysia Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 180 Malaysia Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 181 Malaysia Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 182 Malaysia Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 183 Malaysia Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 184 Malaysia Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 185 Malaysia Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 186 Malaysia Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 187 Rest of Asia Pacific Biosimulation Market, 2020 - 2023, USD Million
- TABLE 188 Rest of Asia Pacific Biosimulation Market, 2024 - 2031, USD Million
- TABLE 189 Rest of Asia Pacific Biosimulation Market by Product, 2020 - 2023, USD Million
- TABLE 190 Rest of Asia Pacific Biosimulation Market by Product, 2024 - 2031, USD Million
- TABLE 191 Rest of Asia Pacific Biosimulation Market by Software Type, 2020 - 2023, USD Million
- TABLE 192 Rest of Asia Pacific Biosimulation Market by Software Type, 2024 - 2031, USD Million
- TABLE 193 Rest of Asia Pacific Biosimulation Market by Services Type, 2020 - 2023, USD Million
- TABLE 194 Rest of Asia Pacific Biosimulation Market by Services Type, 2024 - 2031, USD Million
- TABLE 195 Rest of Asia Pacific Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
- TABLE 196 Rest of Asia Pacific Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
- TABLE 197 Rest of Asia Pacific Biosimulation Market by End Use, 2020 - 2023, USD Million
- TABLE 198 Rest of Asia Pacific Biosimulation Market by End Use, 2024 - 2031, USD Million
- TABLE 199 Rest of Asia Pacific Biosimulation Market by Application, 2020 - 2023, USD Million
- TABLE 200 Rest of Asia Pacific Biosimulation Market by Application, 2024 - 2031, USD Million
- TABLE 201 Rest of Asia Pacific Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
- TABLE 202 Rest of Asia Pacific Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
- TABLE 203 Rest of Asia Pacific Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
- TABLE 204 Rest of Asia Pacific Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
- TABLE 205 Key Information - Certara, Inc.
- TABLE 206 Key Information - Dassault Systemes SE
- TABLE 207 Key Information - Advanced Chemistry Development, Inc.
- TABLE 208 Key Information - Genedata AG
- TABLE 209 Key Information - Instem Group of Companies
- TABLE 210 Key Information - Chemical Computing Group ULC
- TABLE 211 Key Information - Simulations Plus, Inc.
- TABLE 212 Key Information - Schrodinger, Inc.
- TABLE 213 Key Information - PPD, Inc.
- TABLE 214 Key Information - Physiomics Plc
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.